Company intelligence / Profile preview

苏州某生物制药

Ownership: Private
Development stage: Other

Overview

The company has successfully developed a rich pipeline covering multiple oncology indications with several patented inventions authorized internationally. It has completed five major national new drug creation projects. Clinical data specifics are limited publicly but they have advanced candidates into IND stage and beyond.

Therapeutic areas: GastroenterologyHematologyImmunologyOncology
Modalities: Small molecule drugsRecombinant protein drugsAntibody drugs
Industry: Biotech

Beyond the preview

Go deeper on 苏州某生物制药.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 苏州某生物制药.

Explore the full profile